Repligen
RGEN
#2486
Rank
S$9.52 B
Marketcap
S$168.79
Share price
0.63%
Change (1 day)
4.07%
Change (1 year)
Categories

Repligen (RGEN) Fails to deliver data

Key failure to deliver metrics for Repligen :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Repligen (RGEN) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Repligen (RGEN) - since 2013

Volume in USD (price x number of shares), data since 2013

Repligen (RGEN) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026S$24.67 M12.83%
2025S$21.87 M-36.33%
2024S$34.35 M-68.17%
2023S$0.10 B60.05%
2022S$67.43 M90.89%
2021S$35.32 M-76.42%
2020S$0.14 B197.63%
2019S$50.34 M-29.09%
2018S$70.99 M835.37%
2017S$7.59 M22.08%
2016S$6.21 M-19.68%
2015S$7.74 M-7.23%
2014S$8.34 M721.71%
2013S$1.01 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
S$63.7 MS$0.15 B๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$4.05 MS$56.39 M๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$38.71 MS$0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$5.5 MS$63.96 M๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$1.32 MS$7.7 M๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$16.14 MS$60.86 M๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$53.4 MS$65.39 M๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$86.01 MS$0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$4.43 MS$17.27 M๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
S$13.92 MS$0.11 B๐Ÿ‡บ๐Ÿ‡ธ USA